c*****l
发帖数: 739 | 1 Celsion Corporation and Zhejiang Hisun Pharmaceutical Company Enter Into
Technology Development Agreement for ThermoDox� for the Greater China
Territory - MarketWatch
LAWRENCEVILLE, N.J. and TAIZHOU CITY, China, Jan. 22, 2013 /PRNewswire via
COMTEX/ -- Celsion Corporation CLSN -81.17% , a leading oncology drug
development company, and Zhejiang Hisun Pharmaceutical Company Ltd. (sse
code:600267), a leading Chinese pharmaceutical company, today announced that
they have entered into a techno... 阅读全帖 |
|
y*****l
发帖数: 5997 | 2 Celsion Reports First Quarter 2011 Financial Results and Provides Business
Update
Now - Marketwire via Comtex
MarketwireCelsion Corporation (NASDAQ: CLSN), a leading oncology drug
development company, today announced financial results for the first quarter
ended March 31, 2011 and addressed the progress of its clinical trials of
ThermoDox(R), Celsion's proprietary heat-activated liposomal encapsulation
of doxorubicin for the treatment of hepatocellular carcinoma (HCC), commonly
referred to as pr... 阅读全帖 |
|
f**********g
发帖数: 2252 | 3 Celsion Announces Drug Safety Monitoring Board Recommends Advancing DIGNITY
Study of ThermoDox(R) in Recurrent Chest Wall Breast Cancer Into Phase II
1 hours 41 minutes ago - Marketwire via Comtex
MarketwireCelsion Corporation (NASDAQ: CLSN), a leading oncology drug
development company, today announced that after reviewing safety data from
the Company's recently completed Phase I portion of the DIGNITY Phase I/II
study of ThermoDox(R) and hyperthermia in recurrent chest wall (RCW) breast
cancer ... 阅读全帖 |
|
c*****l
发帖数: 739 | 4 Celsion Corporation : Law Firm Brower Piven Announces Investigation of
Investor Securities Fraud Against Celsion Corporation
01/31/2013| 11:50am US/Eastern
The law firm of Brower Piven, A Professional Corporation, is investigating
potential securities fraud claims against Celsion Corporation ("Celsion") (
NASDAQ: CLSN) regarding whether Celsion may have issued materially false or
misleading information to investors before announcing on January 31, 2013
that its ThermoDox liver cancer treatment f... 阅读全帖 |
|
y*****l
发帖数: 5997 | 5 根据光头的分析，好处是股价便宜，还可能用到其它癌症。但是秋季才有结果，效果如
何未知，有风险，效果好的话上升潜力很大。我不是学生物的，不清楚药效，我估计公
司在下个月的会上有好消息公布。盘子小，生拉风险大，只买一点。
About 93% of the 600 patients in the phase III study of Thermodox are
enrolled, Celsion says. Once 190 tumor progression events occur, independent
data monitors will unblind the study for an interim analysis to determine
whether it can be stopped or if it should continue to the final analysis.
Celsion expects this interim look at the Thermodox study to occur in the
third quarter. If the s... 阅读全帖 |
|
y******1
发帖数: 730 | 6 Financial position:
Celsion ended December 31, 2014, with total cash and investments of $37.1
million. Management project that the current cash is enough to support
operating activities for the next two years.
Cash flows/expenses:
In 2014, Celsion used $21.4 million for operations, or approximately $1.8
million per month. Broken down, research and development costs increased to
$15 million versus $9.4 million in 2013, mainly due to initiation of the
OPTIMA study. General and administrative expen... 阅读全帖 |
|
s*****e
发帖数: 1368 | 7 这段时间走得还不错，结果今天冒出了这则消息。从走势结果来看，肯定是不好的。不
过我有点搞不懂今天的走势。从下面的文章来看，应该是买股成交价格在4.25，然后有
优先权每份再买0.3股？如果是这样的话，不应该跌破4啊。如果是一份可以买1.3股的
话（看文章不应该），那应该狂跌到3.27去啊。搞不懂啊。
Celsion Corporation Announces $18.4 Million in Financing
COLUMBIA, MD, Jul 21, 2011 (MARKETWIRE via COMTEX) -- Celsion Corporation (
the "Company") CLSN +0.50% today announced that it has received commitments
from investors to purchase an aggregate of $18.4 million of the Company's
securities, of which $13.0 million are from institutional investo... 阅读全帖 |
|
w****r
发帖数: 245 | 8 大侠，分类都分好了，求神签
# Basic Materials, Agricultural Chemicals
AGU Agrium Inc.
AVD American Vanguard Corp.
CAGC China Agritech Inc.
CF CF Industries Holdings, Inc.
CGA China Green Agriculture, Inc.
CMP Compass Minerals International
COIN Converted Organics Inc.
IPI Intrepid Potash, Inc.
MON Monsanto Co.
MOS Mosaic Co.
NOEC New Oriental Energy & Chemical
POT Potas... 阅读全帖 |
|
S*P
发帖数: 7575 | 9 If you purchased or acquired Celsion securities between January 1, 2012 and
January 30, 2013 and have suffered a loss on your investment, or if you
believe you have information relating to the subject matter of our
investigation, you may email or call Brower Piven, who will, without
obligation or cost to you, communicate with you regarding the matter and
attempt to answer your questions. You may contact Brower Piven by email at
h*****[email protected], by calling 410/415-6616, or by writing to B... 阅读全帖 |
|
|
g**********2
发帖数: 2408 | 11 北京时间1月23日上午消息 据美通社报道，肿瘤药物开发公司Celsion Corporation（
克莱瑞恩公司，NASDAQ: CLSN）和中国制药公司浙江海正宣布达成ThermoDox®（
盐酸多柔比星）在大中华区的技术开发协议。
根据协议规定，海正将立即向克莱瑞恩支付500万美元，而克莱瑞恩将向海正提供
它对 ThermoDox® 制造开发计划的支持。以上支付的500万美元不可退还，而且要
在克莱瑞恩于本月晚些时候披露重要三期试验（HEAT 研究）结果之前支付，该试验涉
及肝细胞癌（HCC，又名原发性肝癌）。
此外，两家公司还预计会签署克莱瑞恩给予海正在大中华市场（包括中国大陆、香
港和澳门）独家开发 ThermoDox® 的选择的协议。选择期将受到第二次支付500万
美元的保障，而克莱瑞恩必须在签署上述技术开发协议后60天内获得来自海正的这笔款
项。预期签署的授权协议的关键条款已经经过了商谈，并得到了双方的赞同，为签署最
终合同奠定了基础。
克莱瑞恩总裁兼首席执行官 Michael H. Tardugno 表示：“与海正签署这份协议
让我们可以评估... 阅读全帖 |
|
|
y******1
发帖数: 730 | 13 Thinly-traded nano cap Celsion (NASDAQ:CLSN) jumps 32% premarket on
robust volume in response to its announcement of positive interim results
from a Phase 2 study assessing ThermoDox in combination with mild
hyperthermia in patients with recurrent chest wall breast cancer, a type of
cancer highly resistant to treatment.
Out of the 16 enrolled patients, 12 were eligible for evaluation for
efficacy. Eight (67%) experienced a clinical benefit while seven (58%)
showed a local response, inclu... 阅读全帖 |
|
发帖数: 1 | 14
我看CLSN很快会增发新股，填补资金窟窿。所以pumping不会持久。
Celsion Corporation @ Lawrenceville, NJ 08648
Full Time Employees: 19
CLSN @ 6.06 +4.55 +301.32%, Volume 73m ★ 145x avg vol. ★
After Hours Trading：6.82 +0.76 Volume 1.7m
Market Cap (intraday) 50.61M ★
Total Cash (mrq) 3.63M
Total Debt (mrq) N/A
Operating Cash Flow -16.71M
Avg Vol (3 month) 541.25k
Shares Outstanding 8.35M
Float 7.31M ★ low float # meets the prerequisite of fast pumping ★
% Held by Insiders 12.38%
% Held by Instituti... 阅读全帖 |
|
|
w***y
发帖数: 2537 | 16 【 以下文字转载自 Stock 讨论区 】
发信人: ll111 (Stealth), 信区: Stock
标 题: Events and ER for week August 2-6
发信站: BBS 未名空间站 (Sun Aug 1 22:47:17 2010, 美东)
Monday, Aug. 2
10 a.m.: ISM Manufacturing index on business activity in July, released by
the Institute for Supply Management.
10:15 a.m. Federal Reserve Chairman Ben Bernanke speaking on "challenges for
the economy and state governments."
4 p.m. Treasury Secretary Timothy Geithner speaking on the next steps for
financial reform.
Tuesday, Aug. 3
8:30 a.m.: P... 阅读全帖 |
|
